跳至主要内容
临床试验/CTRI/2025/02/080052
CTRI/2025/02/080052尚未招募2/3 期

Evaluating the Efficacy of Kataphala (Myrica Nagi) in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease in Mice and Clinical Study

Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年2月27日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To Evaluate the efficacy of Kataphala bark by monitoring the signs and symptoms of patients suffering from Chronic Obstructive Pulmonary Disease.

研究概览

简要总结

The clinical study, which will take place at OPD of the IPGAE&R at SVSP Hospital, is a randomized parallel group, multiple arm trial of a test drug comparing the efficacy of Theophylline for 28 days in 30 patients with Chronic Obstructive Pulmonary Disease. The primary outcome of the research is to evaluate the therapeutic efficacy of test drug in Chronic Obstructive Pulmonary Disease. The secondary outcome is to determine the safety of the test drug on quality of life among the patients suffering from Chronic Obstructive Pulmonary disease.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
35.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Patients who will agree to follow the study protocol of the informed consent and patients who have the following signs and symptoms i)cough with sputum ii) wheezing sound iii) dyspnoea on deep velocity iv)breathlessness.

排除标准

  • below 35 years and above 50 years pre-existing diabetes, hypertension and other systemic disorders pregnancy cardiac disease tuberculosis sexually transmitted disease prostatic hypertrophy hepatic disease HIV positive.

结局指标

主要结局

To Evaluate the efficacy of Kataphala bark by monitoring the signs and symptoms of patients suffering from Chronic Obstructive Pulmonary Disease.

时间窗: 28 days

次要结局

  • Effect of test drug on quality of life among the patients suffering from Chronic Obstructive Pulmonary Disease(28 days)

研究者

发起方
Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Amit Kumar Taraphdar

Institute of Post Graduate Ayurvedic Education and Research at S.V.S.P.

研究点 (1)

Loading locations...

相似试验